Table 1 Novel pancreatic cancer susceptibility loci

From: Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer

Chra SNP Positionb gene

Effect allele (minor)/reference allele

Statistic

PanScan I/II 3535 cases and 3642 controls

PanScan III 1582 cases and 5203 controls

PanC4 3933 cases and 3651 controls

ALL GWAS 9040 cases and 12,496 controls

PANDoRA 2497 cases and 4611 controls

GWAS+PANDoRa 11,537 cases and 17,107 controls

1p36.33 rs13303010 894,573 NOC2L

G/A

MAFc cases;controls

0.14; 0.13

0.12; 0.10

0.13; 0.11

 

0.14; 0.10

 

Infod

0.42

g

g

 

g

 

OR (CI)

1.15 (1.01–1.26)

1.22 (1.09–1.33)

1.16 (1.07–1.24)

1.20 (1.12–1.29)

1.45 (1.33–1.57)

1.26 (1.19–1.35)

 

P value

3.64 × 10−2

1.48 × 10−3

9.54 × 10−4

7.30 × 10−7

6.00 × 10−10

8.36 × 10−14

 

Heterogeneity P valuee

   

6.49 × 10−1

 

4.57 × 10−2

7p12 rs73,328,514 47488569 TNS3

T/A

MAF cases; controls

0.09; 0.11

0.10; 0.12

0.10; 0.12

 

0.10; 0.11

 

Info

0.93

0.97

0.97

 

g

 

OR (CI)

0.80 (0.71–0.89)

0.88 (0.76–1.02)

0.82 (0.74–0.92)

0.83 (0.77–0.88)

0.94 (0.83–1.06)

0.85 (0.80–0.90)

 

P value

8.38 × 10−5

9.31 × 10−2

3.61 × 10−4

4.35 × 10−8

3.08 × 10−1

1.35 × 10−7

 

Heterogeneity P value

   

5.98 × 10−1

 

2.35 × 10−1

8q21.11 rs2941471 76,470,404 HNF4G

G/A

MAF cases; controls

0.40; 0.43

0.41; 0.42

0.41; 0.43

 

0.40; 0.43

 
 

Info

1.0

1.0

1.0

 

g

 
 

OR (CI)

0.87 (0.79–0.94)

0.91 (0.80–1.01)

0.89 (0.82–0.96)

0.89 (0.86–0.94)

0.87 (0.79–0.94)

0.89 (0.85–0.93)

 

P value

2.39 × 10−4

8.30 × 10−2

2.19 × 10−3

4.73 × 10−7

2.42 × 10−4

6.60 × 10−10

 

Heterogeneity P value

   

7.73 × 10−1

 

7.87 × 10−1

17q12 rs4795218 36,078,510 HNF1B

A/G

MAF cases; controls

0.20; 0.23

0.22; 0.23

0.21; 0.23

 

0.21; 0.23

 
 

Info

0.96

0.96

0.95

 

g

 
 

OR (CI)

0.87 (0.80–0.95)

0.88 (0.78–0.98)

0.88 (0.81–0.95)

0.88 (0.82–0.93)

0.90 (0.82–0.98)

0.88 (0.84–0.92)

 

P value

1.12 × 10−3

2.29 × 10−2

1.11 × 10−3

2.73 × 10−7

1.38 × 10−2

1.32 × 10−8

 

Heterogeneity P value

   

9.96 × 10−1

 

9.78 × 10−1

18q21.32 rs1517037 56,878,274 GRP

T/C

MAF cases; controls

0.16; 0.19

0.17; 0.19

0.17; 0.18

 

0.17; 0.19

 
 

Info

g

g

g

 

g

 

OR (CI)

0.82 (0.75–0.89)

0.92 (0.82–1.04)

0.90 (0.83–0.98)

0.87 (0.82–0.93)

0.87 (0.79–0.97)

0.86 (0.80–0.91)

 

P value

7.56 × 10−6

1.90 × 10−1

1.64 × 10−2

8.81 × 10−7

1.17 × 10−2

3.28 × 10−8

 

Heterogeneity P value

   

1.87 × 10-1

7.73 × 10-2

1.03 × 10-1

  1. a Cytogenetic regions according to NCBI Human Genome Build 37
  2. b SNP position according to NCBI Human Genome Build 37
  3. c Minor allele frequency
  4. d Quality of imputation metric. See online methods for more detail. If a SNP is genotyped and not imputed, a “g” is reported
  5. e P value from test of heterogeneity